SEC Comment Letter for Global Pharmatech, Inc. (CIK 0001157300) — Dec 26, 2004
Global Pharmatech, Inc. (CIK 0001157300)
Date: Dec. 26, 2004 · CIK: 0001157300 · Accession: 0000000000-04-041735
AI Filing Summary & Sentiment
File numbers found in text: 333-67884
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
December 26, 2004
Mail Stop 0305
Via U.S. Mail
Simon Thurlow, President
AutoCarbon, Inc.
126 E. 83rd Street, Suite 2F
New York, NY 10028
Re: Form 8-K filed December 16, 2004
File No.: 333-67884
Dear Mr. Thurlow:
We have reviewed your filing and have the following comments.
Where
indicated, we think you should revise your document in response to
this comment.
Please understand that the purpose of our review process is
to
assist you in your compliance with the applicable disclosure
requirements and to enhance the overall disclosure in your filing.
We look forward to working with you in these respects. We welcome
any questions you may have about our comment or on any other
aspect
of our review. Feel free to call us at the telephone numbers
listed
at the end of this letter.
1. We note you have engaged the certified public accountant,
Russell
Brennan (Brennan) effective September 29, 2004. We also note that
Brennan has not applied for registration with the Public Company
Accounting Oversight Board (PCAOB). Section 102 of the Sarbanes-
Oxley Act of 2002 makes it unlawful after October 22, 2003 for any
person that is not a registered public accounting firm (i.e.
registered with the PCAOB) to prepare or issue, or to participate
in
the preparation or issuance of, any audit report (or review
report)
with respect to any issuer. You must engage a new accountant that
is
a publicly registered accounting firm to perform review or audit
work
for the company. Please file a new Item 4 Form 8-K after you have
engaged new accountants that are registered with the PCAOB.
Provide
all of the disclosures required by Item 304 of Regulation S-K
regarding the period of engagement of Brennan which should include
an
Exhibit 16 letter.
Other
2. We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filings reviewed by the staff to
be
certain that they have provided all information investors require.
Since the company and its management are in possession of all
facts
relating to a company`s disclosure, they are responsible for the
accuracy and adequacy of the disclosures they have made.
In connection with responding to our comment, please provide, in
writing, a statement from the company acknowledging that
* the company is responsible for the adequacy and accuracy of the
disclosure in the filings;
* staff comments or changes to disclosure in response to staff
comments in the filings reviewed by the staff do not foreclose the
Commission from taking any action with respect to the filing; and
* the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
In addition, please be advised that the Division of Enforcement
has
access to all information you provide to the staff of the Division
of
Corporation Finance in our review of your filing or in response to
our comments on your filing.
We welcome any questions you may have about our comments or on any
other aspect of our review. You may contact me at 202-942-1785,
or
in my absence, Robert Benton at 202-942-1811.
Sincerely,
Theresa A. Messinese, CPA
Staff Accountant
??
??
??
??
Simon Thurlow
AutoCarbon, Inc.
December 26, 2004
Page 2
</TEXT>
</DOCUMENT>